Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 22 |
NetGPI | no | yes: 0, no: 22 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 21 |
GO:0110165 | cellular anatomical entity | 1 | 22 |
GO:0016020 | membrane | 2 | 3 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0031019 | mitochondrial mRNA editing complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0045293 | mRNA editing complex | 3 | 1 |
GO:0098798 | mitochondrial protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: A4HGC0
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 23 |
GO:0006396 | RNA processing | 6 | 23 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 23 |
GO:0006807 | nitrogen compound metabolic process | 2 | 23 |
GO:0008152 | metabolic process | 1 | 23 |
GO:0009987 | cellular process | 1 | 23 |
GO:0016070 | RNA metabolic process | 5 | 23 |
GO:0031123 | RNA 3'-end processing | 7 | 23 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 23 |
GO:0043170 | macromolecule metabolic process | 3 | 23 |
GO:0044237 | cellular metabolic process | 2 | 23 |
GO:0044238 | primary metabolic process | 2 | 23 |
GO:0046483 | heterocycle metabolic process | 3 | 23 |
GO:0071076 | RNA 3' uridylation | 8 | 23 |
GO:0071704 | organic substance metabolic process | 2 | 23 |
GO:0090304 | nucleic acid metabolic process | 4 | 23 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 23 |
GO:0006378 | mRNA polyadenylation | 7 | 1 |
GO:0006397 | mRNA processing | 7 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0031124 | mRNA 3'-end processing | 8 | 1 |
GO:0043631 | RNA polyadenylation | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 23 |
GO:0004652 | obsolete polynucleotide adenylyltransferase activity | 6 | 5 |
GO:0005488 | binding | 1 | 23 |
GO:0016740 | transferase activity | 2 | 23 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 23 |
GO:0016779 | nucleotidyltransferase activity | 4 | 23 |
GO:0043167 | ion binding | 2 | 23 |
GO:0043169 | cation binding | 3 | 23 |
GO:0046872 | metal ion binding | 4 | 23 |
GO:0050265 | RNA uridylyltransferase activity | 4 | 23 |
GO:0070566 | adenylyltransferase activity | 5 | 5 |
GO:0070569 | uridylyltransferase activity | 5 | 23 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 23 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 23 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 349 | 351 | PF00675 | 0.317 |
CLV_NRD_NRD_1 | 378 | 380 | PF00675 | 0.438 |
CLV_NRD_NRD_1 | 416 | 418 | PF00675 | 0.482 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.410 |
CLV_NRD_NRD_1 | 52 | 54 | PF00675 | 0.355 |
CLV_PCSK_KEX2_1 | 418 | 420 | PF00082 | 0.498 |
CLV_PCSK_KEX2_1 | 45 | 47 | PF00082 | 0.390 |
CLV_PCSK_KEX2_1 | 52 | 54 | PF00082 | 0.362 |
CLV_PCSK_PC1ET2_1 | 418 | 420 | PF00082 | 0.573 |
CLV_PCSK_SKI1_1 | 198 | 202 | PF00082 | 0.339 |
CLV_PCSK_SKI1_1 | 406 | 410 | PF00082 | 0.498 |
CLV_PCSK_SKI1_1 | 443 | 447 | PF00082 | 0.451 |
CLV_Separin_Metazoa | 42 | 46 | PF03568 | 0.498 |
DEG_APCC_DBOX_1 | 197 | 205 | PF00400 | 0.322 |
DEG_APCC_DBOX_1 | 405 | 413 | PF00400 | 0.523 |
DEG_SPOP_SBC_1 | 133 | 137 | PF00917 | 0.482 |
DOC_CYCLIN_RxL_1 | 336 | 345 | PF00134 | 0.482 |
DOC_CYCLIN_RxL_1 | 46 | 58 | PF00134 | 0.248 |
DOC_CYCLIN_yCln2_LP_2 | 155 | 161 | PF00134 | 0.413 |
DOC_MAPK_MEF2A_6 | 146 | 155 | PF00069 | 0.367 |
DOC_PP1_RVXF_1 | 409 | 415 | PF00149 | 0.510 |
DOC_PP2B_LxvP_1 | 155 | 158 | PF13499 | 0.379 |
DOC_USP7_MATH_1 | 133 | 137 | PF00917 | 0.420 |
DOC_USP7_MATH_1 | 82 | 86 | PF00917 | 0.613 |
DOC_USP7_UBL2_3 | 376 | 380 | PF12436 | 0.552 |
DOC_WW_Pin1_4 | 78 | 83 | PF00397 | 0.457 |
LIG_14-3-3_CanoR_1 | 383 | 389 | PF00244 | 0.491 |
LIG_14-3-3_CanoR_1 | 391 | 399 | PF00244 | 0.462 |
LIG_14-3-3_CanoR_1 | 417 | 422 | PF00244 | 0.505 |
LIG_14-3-3_CanoR_1 | 45 | 54 | PF00244 | 0.509 |
LIG_14-3-3_CanoR_1 | 73 | 79 | PF00244 | 0.507 |
LIG_BRCT_BRCA1_1 | 123 | 127 | PF00533 | 0.477 |
LIG_deltaCOP1_diTrp_1 | 120 | 127 | PF00928 | 0.389 |
LIG_eIF4E_1 | 196 | 202 | PF01652 | 0.291 |
LIG_eIF4E_1 | 8 | 14 | PF01652 | 0.435 |
LIG_FHA_1 | 13 | 19 | PF00498 | 0.462 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.387 |
LIG_FHA_1 | 366 | 372 | PF00498 | 0.537 |
LIG_FHA_1 | 440 | 446 | PF00498 | 0.536 |
LIG_FHA_2 | 115 | 121 | PF00498 | 0.448 |
LIG_FHA_2 | 279 | 285 | PF00498 | 0.304 |
LIG_FHA_2 | 357 | 363 | PF00498 | 0.514 |
LIG_FHA_2 | 385 | 391 | PF00498 | 0.345 |
LIG_FHA_2 | 435 | 441 | PF00498 | 0.469 |
LIG_LIR_Apic_2 | 166 | 171 | PF02991 | 0.380 |
LIG_LIR_Gen_1 | 124 | 133 | PF02991 | 0.441 |
LIG_LIR_Gen_1 | 81 | 91 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 124 | 130 | PF02991 | 0.427 |
LIG_LIR_Nem_3 | 24 | 30 | PF02991 | 0.339 |
LIG_LIR_Nem_3 | 260 | 264 | PF02991 | 0.419 |
LIG_LIR_Nem_3 | 281 | 285 | PF02991 | 0.311 |
LIG_LIR_Nem_3 | 81 | 86 | PF02991 | 0.536 |
LIG_Pex14_1 | 121 | 125 | PF04695 | 0.510 |
LIG_Pex14_2 | 170 | 174 | PF04695 | 0.345 |
LIG_Pex14_2 | 282 | 286 | PF04695 | 0.451 |
LIG_PTB_Apo_2 | 255 | 262 | PF02174 | 0.567 |
LIG_PTB_Phospho_1 | 255 | 261 | PF10480 | 0.567 |
LIG_SH2_CRK | 168 | 172 | PF00017 | 0.356 |
LIG_SH2_STAP1 | 196 | 200 | PF00017 | 0.289 |
LIG_SH2_STAP1 | 224 | 228 | PF00017 | 0.306 |
LIG_SH2_STAP1 | 3 | 7 | PF00017 | 0.389 |
LIG_SH2_STAT5 | 277 | 280 | PF00017 | 0.388 |
LIG_SH2_STAT5 | 285 | 288 | PF00017 | 0.388 |
LIG_SH2_STAT5 | 348 | 351 | PF00017 | 0.400 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.355 |
LIG_SH3_1 | 76 | 82 | PF00018 | 0.453 |
LIG_SH3_2 | 378 | 383 | PF14604 | 0.432 |
LIG_SH3_3 | 148 | 154 | PF00018 | 0.353 |
LIG_SH3_3 | 375 | 381 | PF00018 | 0.398 |
LIG_SH3_3 | 76 | 82 | PF00018 | 0.453 |
LIG_SUMO_SIM_par_1 | 29 | 34 | PF11976 | 0.461 |
LIG_SUMO_SIM_par_1 | 368 | 375 | PF11976 | 0.281 |
LIG_TRAF2_1 | 263 | 266 | PF00917 | 0.319 |
LIG_UBA3_1 | 200 | 206 | PF00899 | 0.345 |
LIG_WRC_WIRS_1 | 279 | 284 | PF05994 | 0.277 |
LIG_WW_3 | 380 | 384 | PF00397 | 0.490 |
MOD_CK1_1 | 372 | 378 | PF00069 | 0.482 |
MOD_CK1_1 | 397 | 403 | PF00069 | 0.517 |
MOD_CK2_1 | 114 | 120 | PF00069 | 0.468 |
MOD_CK2_1 | 278 | 284 | PF00069 | 0.304 |
MOD_CK2_1 | 96 | 102 | PF00069 | 0.350 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.335 |
MOD_GlcNHglycan | 344 | 347 | PF01048 | 0.353 |
MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.420 |
MOD_GlcNHglycan | 98 | 101 | PF01048 | 0.441 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.449 |
MOD_GSK3_1 | 220 | 227 | PF00069 | 0.329 |
MOD_GSK3_1 | 292 | 299 | PF00069 | 0.424 |
MOD_GSK3_1 | 365 | 372 | PF00069 | 0.554 |
MOD_GSK3_1 | 55 | 62 | PF00069 | 0.373 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.451 |
MOD_N-GLC_1 | 114 | 119 | PF02516 | 0.461 |
MOD_N-GLC_1 | 121 | 126 | PF02516 | 0.406 |
MOD_N-GLC_1 | 433 | 438 | PF02516 | 0.629 |
MOD_NEK2_1 | 13 | 18 | PF00069 | 0.400 |
MOD_NEK2_1 | 132 | 137 | PF00069 | 0.367 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.334 |
MOD_NEK2_1 | 181 | 186 | PF00069 | 0.328 |
MOD_NEK2_1 | 220 | 225 | PF00069 | 0.332 |
MOD_NEK2_1 | 278 | 283 | PF00069 | 0.287 |
MOD_NEK2_1 | 369 | 374 | PF00069 | 0.509 |
MOD_NEK2_2 | 3 | 8 | PF00069 | 0.438 |
MOD_PKA_1 | 417 | 423 | PF00069 | 0.493 |
MOD_PKA_1 | 45 | 51 | PF00069 | 0.501 |
MOD_PKA_2 | 181 | 187 | PF00069 | 0.337 |
MOD_PKA_2 | 208 | 214 | PF00069 | 0.301 |
MOD_PKA_2 | 45 | 51 | PF00069 | 0.361 |
MOD_PKA_2 | 72 | 78 | PF00069 | 0.437 |
MOD_PKB_1 | 107 | 115 | PF00069 | 0.370 |
MOD_PKB_1 | 57 | 65 | PF00069 | 0.264 |
MOD_Plk_1 | 114 | 120 | PF00069 | 0.418 |
MOD_Plk_1 | 121 | 127 | PF00069 | 0.401 |
MOD_Plk_1 | 3 | 9 | PF00069 | 0.426 |
MOD_Plk_4 | 134 | 140 | PF00069 | 0.489 |
MOD_Plk_4 | 224 | 230 | PF00069 | 0.311 |
MOD_Plk_4 | 232 | 238 | PF00069 | 0.334 |
MOD_Plk_4 | 278 | 284 | PF00069 | 0.451 |
MOD_Plk_4 | 3 | 9 | PF00069 | 0.406 |
MOD_Plk_4 | 356 | 362 | PF00069 | 0.443 |
MOD_Plk_4 | 365 | 371 | PF00069 | 0.492 |
MOD_ProDKin_1 | 78 | 84 | PF00069 | 0.453 |
TRG_DiLeu_BaEn_1 | 274 | 279 | PF01217 | 0.354 |
TRG_ENDOCYTIC_2 | 261 | 264 | PF00928 | 0.416 |
TRG_ER_diArg_1 | 106 | 109 | PF00400 | 0.483 |
TRG_ER_diArg_1 | 44 | 46 | PF00400 | 0.399 |
TRG_ER_diArg_1 | 51 | 53 | PF00400 | 0.355 |
TRG_ER_diArg_1 | 56 | 59 | PF00400 | 0.289 |
TRG_NLS_MonoExtC_3 | 416 | 422 | PF00514 | 0.592 |
TRG_Pf-PMV_PEXEL_1 | 262 | 266 | PF00026 | 0.454 |
TRG_Pf-PMV_PEXEL_1 | 339 | 344 | PF00026 | 0.400 |
TRG_Pf-PMV_PEXEL_1 | 386 | 390 | PF00026 | 0.589 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P857 | Leptomonas seymouri | 75% | 87% |
A0A0N1IJQ4 | Leptomonas seymouri | 24% | 90% |
A0A0S4JJR1 | Bodo saltans | 22% | 91% |
A0A0S4JJT6 | Bodo saltans | 44% | 78% |
A0A1X0NSS0 | Trypanosomatidae | 23% | 93% |
A0A1X0NZU6 | Trypanosomatidae | 58% | 87% |
A0A3Q8IC11 | Leishmania donovani | 25% | 89% |
A0A3Q8IHZ8 | Leishmania donovani | 90% | 100% |
A0A3R7K3P5 | Trypanosoma rangeli | 55% | 86% |
A0A422NVH7 | Trypanosoma rangeli | 23% | 93% |
A4HEP5 | Leishmania braziliensis | 25% | 100% |
A4I1X5 | Leishmania infantum | 25% | 89% |
A4I3F3 | Leishmania infantum | 89% | 100% |
C9ZS45 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 23% | 93% |
D0A7Y7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 57% | 86% |
E9AY21 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 89% |
E9AZP1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q8J1 | Leishmania major | 89% | 100% |
Q4Q9F2 | Leishmania major | 25% | 100% |
Q86MV5 | Trypanosoma brucei brucei | 23% | 93% |
V5BG78 | Trypanosoma cruzi | 55% | 86% |
V5BQ07 | Trypanosoma cruzi | 23% | 94% |